dabigatran has been researched along with Cognitive Decline in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sharma, M | 1 |
Bunch, TJ; Crandall, B; Cutler, M; Day, JD; Jacobs, V; Mallender, C; May, H; Olson, J; Osborn, J; Stevens, SM; Weiss, JP; Woller, SC | 1 |
Ho, P; La Brooy, B; Lim, K | 1 |
1 trial(s) available for dabigatran and Cognitive Decline
Article | Year |
---|---|
Rationale and design of the impact of anticoagulation therapy on the Cognitive Decline and Dementia in Patients with Nonvalvular Atrial Fibrillation (CAF) Trial: A Vanguard study.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Cognition; Cognitive Dysfunction; Dabigatran; Dementia; Female; Humans; Incidence; International Normalized Ratio; Male; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Treatment Outcome; Warfarin | 2019 |
2 other study(ies) available for dabigatran and Cognitive Decline
Article | Year |
---|---|
Preventing Alzheimer's Disease: Some Light in the Darkness.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cognitive Dysfunction; Dabigatran; Humans; Mice; Time-to-Treatment | 2019 |
Reversible Cognitive Impairment Associated with the Use of Dabigatran.
Topics: Aged, 80 and over; Antithrombins; Benzimidazoles; beta-Alanine; Cognition; Cognitive Dysfunction; Dabigatran; Follow-Up Studies; Humans; Male; Recovery of Function; Stroke | 2015 |